You are here: Industry Insights > MHRA

News List

MHRA suspends patient recruitment to UK COVID-19 hydroxychloroquine trials europeanpharmaceuticalreview
June 18, 2020
After evidence suggesting hydroxychloroquine has no benefit against COVID-19, the MHRA has suspended further recruitment to clinical trials investigating the drug in the UK.
MHRA suspends COVID-19 hydroxychloroquine trials pharmatimes
June 17, 2020
As of this morning – Wednesday June 17 – the current recorded case count for COVID-19 (coronavirus) in the UK has reached 298,136 with 41,969 deaths.
CASI Pharmaceuticals Announces Submission Of Clinical Trial Application (IND) To Conduct Phase 1 Study For Anti-38 Monoclonal Antibody Program prnewswire
June 09, 2020
CASI Pharmaceuticals, Inc. announced that it submitted a Clinical Trial Application (CTA) (IND) with the United Kingdom's Medicines and Healthcare Products Regulatory Agency (MHRA) for CID-103.
MHRA issues Medicines Defect Information alert for levofloxacin tablets europeanpharmaceuticalreview
April 20, 2020
Teva has informed the MHRA that the GTIN number found on a batch of levofloxacin tablets is incorrect, prompting the Medicines Defect Information alert.
Ridgeback Biotherapeutics announces MHRA clearance to begin human testing of EIDD-2801 in UK for COVID-19 pharmaceutical-business-review
April 16, 2020
Ridgeback Biotherapeutics announced clearance by the UK Medicines and Healthcare products Regulatory Agency (MHRA).
UK and Europe tackle false COVID-19 medicinal products europeanpharmaceuticalreview
April 09, 2020
The MHRA and Council of Europe have both announced measures to prevent the spread of falsified or unlicensed COVID-19 medical products.
MHRA issues Class 4 Medicines Defect Information for paracetamol europeanpharmaceuticalreview
April 03, 2020
A barcode for paracetamol 250mg/5ml oral suspension displays the wrong strength when scanned, prompting the MHRA to announce the defect information.
MHRA issues FMD over HMS Wholesale Limited products europeanpharmaceuticalreview
March 25, 2020
A Class 4 falsified medicines directive (FMD) has been issued by the MHRA because medicines may have left the legal supply chain to be reintroduced later through HMS Wholesale Limited.
Global operation identifies 34,000 falsifed coronavirus medicines europeanpharmaceuticalreview
March 23, 2020
Operation Pangea has revealed a large number of falsified coronavirus treatments, while the MHRA has seized 871,616 doses of other unlicensed medicines.
MHRA issues Medicine Defect Information about Aripiprazole europeanpharmaceuticalreview
March 13, 2020
The regulatory body has issued guidance based on a complaint that stated a precipitate formed in Aripiprazole 1mg/ml oral solution.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page